Adverse events330

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 330

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	2	18	6
other	Anaemia	Blood and lymphatic system disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	2	6	5
other	Neutropenia	Blood and lymphatic system disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	2
other	Neutropenia	Blood and lymphatic system disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	1
other	Thrombocytopenia	Blood and lymphatic system disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	2	6	3
other	Angina pectoris	Cardiac disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	1
other	Angina pectoris	Cardiac disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0
other	Tachycardia	Cardiac disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	2	18	2
other	Tachycardia	Cardiac disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0
other	Ear discomfort	Ear and labyrinth disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	1
other	Ear discomfort	Ear and labyrinth disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0
other	Cataract	Eye disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	2
other	Cataract	Eye disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0
other	Chalazion	Eye disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	0	18	0
other	Chalazion	Eye disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	1	6	1
other	Eye pain	Eye disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	1
other	Eye pain	Eye disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0
other	Glaucoma	Eye disorders	Regorafenib(Stivarga, BAY73-4506)-Normal/Mild Impairment	1	18	1
other	Glaucoma	Eye disorders	Regorafenib(Stivarga,BAY73-4506)-Severe Renal Impairment	0	6	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01853046/events

API reference For AI assistants

Adverse events330

Sources 3

Read this list from software.